VERKMAN; Alan

Patent Applications and Registrations

Patent applications and USPTO patent grants for VERKMAN; Alan.The latest application filed is for "recombinant igg fc multimers for the treatment of neuromyelitis optica".

Company Profile

1.8.14

VERKMAN; Alan - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA App 20210095006 - SPIRIG; Rolf ; et al.	2021-04-01
Compounds Having Activity in Increasing Ion Transport by Mutant-CFTR and Uses Thereof App 20120101143 - Verkman; Alan ; et al.	2012-04-26
Compounds having activity in correcting mutant-CFTR processing and uses thereof Grant 8,143,295 - Verkman , et al. March 27, 2	2012-03-27
Water-soluble, fluorescent compounds for detection of potassium ions Grant 8,129,365 - Verkman , et al. March 6, 2	2012-03-06
Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof Grant 8,058,295 - Verkman , et al. November 15, 2	2011-11-15
Hydrazide-containing Cftr Inhibitor Compounds And Uses Thereof App 20110119775 - Verkman; Alan ; et al.	2011-05-19
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof Grant 7,939,558 - Verkman , et al. May 10, 2	2011-05-10
Cystic Fibrosis Transmembrane Conductance Regulator Protein Inhibitors And Uses Thereof App 20100130571 - Verkman; Alan ; et al.	2010-05-27
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof Grant 7,696,244 - Verkman , et al. April 13, 2	2010-04-13
Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof Grant 7,638,543 - Verkman , et al. December 29, 2	2009-12-29
Hydrazide-containing Cftr Inhibitor Compounds And Uses Thereof App 20090048207 - Verkman; Alan ; et al.	2009-02-19
Compounds Having Activity in Correcting Mutant-Cftr Processing and Uses Thereof App 20080318984 - Verkman; Alan ; et al.	2008-12-25
Compounds Having Activity in Increasing Ion Transport by Mutant-Cftr and Uses Thereof App 20080319008 - Verkman; Alan ; et al.	2008-12-25
Water-Soluble, Fluorescent Compounds for Detection of Potassium Ions App 20080311041 - Verkman; Alan ; et al.	2008-12-18
Modulation of Aquaporin in Modulation of Angiogenesis and Cell Migration App 20080221120 - Verkman; Alan	2008-09-11
Hydrazide-containing CFTR inhibitor compounds and uses thereof Grant 7,414,037 - Verkman , et al. August 19, 2	2008-08-19
Cystic Fibrosis Transmembrane Conductance Regulator Protein Inhibitors And Uses Thereof App 20080064666 - Verkman; Alan ; et al.	2008-03-13
Compounds Having Activity in Increasing Ion Transport by Mutant-Cftr and Uses Thereof App 20070265316 - Verkman; Alan ; et al.	2007-11-15
Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors Grant 7,235,573 - Verkman , et al. June 26, 2	2007-06-26
Hydrazide-containing CFTR inhibitor compounds and uses thereof App 20050239740 - Verkman, Alan ; et al.	2005-10-27
Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof App 20040235800 - Verkman, Alan ; et al.	2004-11-25
Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof App 20040063695 - Verkman, Alan ; et al.	2004-04-01

Company Registrations

NCAGE Code	3QBP2	VERKMAN ALAN
CAGE Code	3QBP2	VERKMAN, ALAN
DUNS	142402762	VERKMAN, ALAN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.